Cockroach Nasal Allergen Challenge Pilot
Completed · Phase 1
Conditions studied: Asthma, Cockroach Hypersensitivity
In brief
This research is being done to look at the body's response to cockroach extract, an allergen, when sprayed into the nose. The spraying of the cockroach extract into the participant's nose is called Nasal Allergen Challenge (NAC). The purpose of this study is to evaluate the safety and tolerability of a intranasal cockroach extract given to participants with asthma.
Key facts
- Study ID
- NCT02710136
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
- People needed
- 35
- Starts
- 2016-02-01
- Expected to finish
- 2017-04-11
- Last updated by the study team
- 2018-09-25
Who can join
Age: 8 and older, up to 55. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Children's Hospital Colorado — Aurora, Colorado, United States
- Children's National Medical Center — Washington D.C., District of Columbia, United States
- Cincinnati Children's Hospital — Cincinnati, Ohio, United States
- UT Southwestern Medical Center — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.